Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces the launch of VivoSight Dx, the Company’s second generation OCT system, at the German Society of Dermatology 48th Congress 2015 (DDG 2015), 29th April – 2nd May 2015, Berlin.
VivoSight Dx is aimed at dermatologists seeking an imaging system that will enhance their ability to make rapid, accurate diagnostic decisions for their patients. It is lighter, more compact and more mobile than the first generation OCT system, enabling its use in a consulting room at short notice. VivoSight Dx also features a completely new graphical user interface, designed to make the patient scan and image-assessment workflow very fast and efficient for maximum patient throughput.
To view the full article please click here